Skip to content

Autogenous Bone Ring Versus Split Bone Block for Management of Posterior Atrophic Mandible

Autogenous Bone Ring Versus Split Bone Block With Simultaneous Implant Placement for Management of Posterior Atrophic Mandible (A Randomized Clinical Trial)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07140887
Enrollment
16
Registered
2025-08-26
Start date
2024-08-26
Completion date
2025-08-05
Last updated
2025-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ridge Augmentation

Keywords

Bone ring, trephine, piezotome, ridge augmentation, Khoury technique, implant

Brief summary

Teeth loss in the posterior mandible initiates residual ridge resorption especially in vertical direction, this causes difficulty in implant placement so ridge augmentation must be done either simultaneous with implant placement or in a staged approach Aim: To evaluate the effect of bone ring technique versus split bone block technique with simultaneous implant clinically on primary and secondary

Interventions

OTHERBone Ring

Patients in this group will be treated with the bone ring technique. An implant drill will be used next to prepare central osteotomies corresponding to the final implant diameter to be placed in the center of the disc converting it to a bone ring.

OTHERSplit Bone block

Patients of this group will be treated with split bone block with simultaneous implant technique. The bone shell will be split into two bone shells each 1 \ 2 mm in thickness using a disc.

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
35 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Patients with missing posterior mandibular teeth. * Vertical bone defect from 3 to 4 mm. * Adequate zone of keratinized tissue.

Exclusion criteria

* Presence of infection or periapical lesions in adjacent teeth. * Medically compromised patients with a condition that affects the procedure. * Insufficient inter-arch distance. * Bruxism or clenching. * Alcoholism. * Heavy Smokers.

Design outcomes

Primary

MeasureTime frameDescription
Change in implant stabilityImmediate and 6 monthsImplant stability will be recorded immediately after placement (1ry stability) and after 6 months (2ry stability ) by using osstell device. The result is presented in form of ISQ value from 1to 100, the higher the ISQ the higher the stability of implant(
Change in pain scoresup to 7 daysPain will be assessed for 7 days postoperatively using 10-point visual analouge scale (VAS) (0-1=None, 2-4=mild, 5-7=moderate, 8-10=severe ).
Change in marginal bone level6 and 9 monthsAt buccal, lingual, mesial, and distal sites will be evaluated radiographically from the shoulder of the implant to the alveolar crest.

Secondary

MeasureTime frameDescription
Change in bone density6 monthsWill be measured at 6 points around the implant and a mean value will be calculated using CBCT
Change in edemaup to 7 daysMeasured as follows: No inflammation = none. Intra oral swelling confined to the surgical field = mild. Extra oral swelling in the surgical zone =moderate. Extra oral swelling spreading beyond the surgical zone =intense.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026